BrightPath Biotherapeutics Co., Ltd. (TYO:4594)
Japan flag Japan · Delayed Price · Currency is JPY
82.00
+30.00 (57.69%)
Jul 4, 2025, 3:30 PM JST

TYO:4594 Cash Flow Statement

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025 FY 2024 FY 2018 FY 2017
Period Ending
Mar '25 Mar '24 Mar '18 Mar '17
Net Income
-1,151-1,168-1,573-1,116
Depreciation & Amortization
-0.47341
Asset Writedown & Restructuring Costs
1.377.25--
Other Operating Activities
-103.060.7-313
Change in Accounts Receivable
-1.140.05-2251
Change in Inventory
--14-6
Change in Accounts Payable
0.02-0.06-13-41
Change in Other Net Operating Assets
3.612.82-67-9
Operating Cash Flow
-1,250-1,157-1,591-1,067
Capital Expenditures
-1.37-6.19-108-97
Cash Acquisitions
---7
Sale (Purchase) of Intangibles
--1.45-3-6
Investing Cash Flow
-1.37-7.65-111-96
Long-Term Debt Issued
500500--
Long-Term Debt Repaid
-587.5-387.5--
Net Debt Issued (Repaid)
-87.5112.5--
Issuance of Common Stock
1,093578.463,2813,559
Repurchase of Common Stock
-1.04---
Other Financing Activities
-00--
Financing Cash Flow
1,005690.963,2813,559
Miscellaneous Cash Flow Adjustments
---1-1
Net Cash Flow
-246.89-473.611,5782,395
Free Cash Flow
-1,252-1,163-1,699-1,164
Free Cash Flow Margin
-110479.17%-1615436.11%-479.94%-220.04%
Free Cash Flow Per Share
-15.36-18.13-44.44-34.22
Cash Income Tax Paid
1.91.932
Levered Free Cash Flow
-836.04--1,029-
Unlevered Free Cash Flow
-836.04--1,029-
Change in Net Working Capital
109.1-15-
Updated Feb 14, 2019. Source: S&P Global Market Intelligence. Standard template. Financial Sources.